Skip to main navigation Skip to search Skip to main content

Consenting not to be informed: A survey on the acceptability of placebo use in the treatment of depression

  • Shalvata Mental Health Center
  • Herzog Hospital Jerusalem
  • Zefat Academic College

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

The aim of this study was to investigate the opinions of healthy students regarding the acceptability of placebo treatment if they were to experience depression. A survey was conducted among 344 students in five academic centers in Israel. After a thorough explanation of the placebo effect, its efficacy and limitations in the treatment of depression, the study participants completed a 32-item self-report questionnaire. Seventy percent (n = 243) of the participants answered that they would agree to treatment with a placebo as a first-line treatment if they were to experience depression in the future. Eighty-eight percent (n = 297) of the subjects did not think that a physician who administered placebos was deceitful. Once aware of the possible benefits and limitations of placebo treatment, most of our study population was willing to accept placebo as a legitimate treatment of depression. Additional studies on the possible use of placebo as an effective, safe, and acceptable form of therapy are warranted.

Original languageEnglish
Pages (from-to)345-347
Number of pages3
JournalJournal of Nervous and Mental Disease
Volume201
Issue number4
DOIs
StatePublished - Apr 2013

Keywords

  • Placebo
  • depression
  • informed consent
  • treatment

Fingerprint

Dive into the research topics of 'Consenting not to be informed: A survey on the acceptability of placebo use in the treatment of depression'. Together they form a unique fingerprint.

Cite this